NovaBay Signs Agreement With Nation’s Second Largest Independent Optometry Group, ALLDocs

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on commercializing and developing non-antibiotic antimicrobial products for the global eye care market, today announced that the company’s prescription daily eyelid and lash hygiene product Avenova™ will be marketed through ALLDocs Optometry Group, making the product available to the group’s optometrists.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC